Skip to content
10-Q

Quarterly Report

VANSEN PHARMA INC.

0001477932-12-004456

← back to feed
Filed
Nov 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 15, 2012 3.53M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$25.67K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$213.11K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$11.69K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $18.09K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $18.77K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $58
Stockholders Equity Q3 2012 · Sep 30, 2012 −$98.89K
Stockholders Equity Q3 2012 · Dec 31, 2011 −$98.78K
Current Liabilities Q3 2012 · Sep 30, 2012 $116.98K
Current Liabilities Q3 2012 · Dec 31, 2011 $117.55K
Total Liabilities Q3 2012 · Sep 30, 2012 $116.98K
Total Liabilities Q3 2012 · Dec 31, 2011 $117.55K
Current Assets Q3 2012 · Sep 30, 2012 $18.09K
Current Assets Q3 2012 · Dec 31, 2011 $18.77K
Total Assets Q3 2012 · Sep 30, 2012 $18.09K
Total Assets Q3 2012 · Dec 31, 2011 $18.77K
Sga Expense Q3 2012 · Sep 30, 2012 $3.63K
Sga Expense Q3 2012 · Sep 30, 2012 $10.96K
Sga Expense Q3 2012 · Sep 30, 2012 $56.38K
Sga Expense Q3 2012 · Sep 30, 2011 $1.65K
Sga Expense Q3 2012 · Sep 30, 2011 $3.71K
Net Income Q3 2012 · Sep 30, 2012 −$29.75K
Net Income Q3 2012 · Sep 30, 2012 −$242.67K
Net Income Q3 2012 · Sep 30, 2011 −$17.09K